⚡️🇺🇸#TMO #отчетность
Thermo Fisher Scientific Q2 22 Earnings:
- Adj EPS: $5.51 (est $5.00)
- Revenue: $10.97B (est $9.97B)
Thermo Fisher Scientific Q2 22 Earnings:
- Adj EPS: $5.51 (est $5.00)
- Revenue: $10.97B (est $9.97B)
⚡️🇷🇺#GMKN #отчетность
НОРНИКЕЛЬ ВО II КВАРТАЛЕ ПРОИЗВЕЛ 709 ТЫС. УНЦИЙ ПАЛЛАДИЯ, НА УРОВНЕ ПРЕДЫДУЩЕГО ПЕРИОДА
полный отчет
НОРНИКЕЛЬ ВО II КВАРТАЛЕ ПРОИЗВЕЛ 709 ТЫС. УНЦИЙ ПАЛЛАДИЯ, НА УРОВНЕ ПРЕДЫДУЩЕГО ПЕРИОДА
полный отчет
🇺🇸#акции #сша #инсайдеры #правительство
в августе - Демократы Палаты представителей США планируют предложить запретить торговлю акциями чиновникам - Punchbowl News
в августе - Демократы Палаты представителей США планируют предложить запретить торговлю акциями чиновникам - Punchbowl News
⚡️🇺🇸#MRK #отчетность
Merck Q2 22 Earnings:
- Adj EPS: $1.87 (est $1.70)
- Revenue: $14.6B (est $13.85B)
- Keytruda Rev: $5.3B (est $4.91B)
- See’s FY Sales $57.5B To $58.5B, Saw $56.9B To $58.1B
Merck Q2 22 Earnings:
- Adj EPS: $1.87 (est $1.70)
- Revenue: $14.6B (est $13.85B)
- Keytruda Rev: $5.3B (est $4.91B)
- See’s FY Sales $57.5B To $58.5B, Saw $56.9B To $58.1B
⚡️🇺🇸#HON #отчетность
Honeywell Q2 22 Earnings:
- Adj EPS: $2.10 (est $2.03)
- Revenue: $8.95B (est $8.66B)
- See’s FY Sales $35.5B To $36.1B, Saw $35.5B To $36.4B
Honeywell Q2 22 Earnings:
- Adj EPS: $2.10 (est $2.03)
- Revenue: $8.95B (est $8.66B)
- See’s FY Sales $35.5B To $36.1B, Saw $35.5B To $36.4B
⚡️🇺🇸#ARCH #отчетность
Arch Resources
Q2 GAAP EPS of $19.30.
Revenue of $1.13B (+150.9% Y/Y).
Delivers record net income for a third straight quarter
#дивиденд Announces a quarterly dividend of $118.7 million, or $6.00 per share
Arch Resources
Q2 GAAP EPS of $19.30.
Revenue of $1.13B (+150.9% Y/Y).
Delivers record net income for a third straight quarter
#дивиденд Announces a quarterly dividend of $118.7 million, or $6.00 per share
⚡️🇺🇸#VLO #отчетность
Valero Energy Q2 22 Earnings:
- Adj EPS: $11.36 (est $9.56)
- Revenue: $51.64B (est $42.90B)
Reduced debt by $300 million through the acquisition of the 4.00 percent Gulf Opportunity Zone Revenue Bonds (GO Zone Bonds), reducing Valero’s debt by $2.3 billion since the second half of 2021
Valero Energy Q2 22 Earnings:
- Adj EPS: $11.36 (est $9.56)
- Revenue: $51.64B (est $42.90B)
Reduced debt by $300 million through the acquisition of the 4.00 percent Gulf Opportunity Zone Revenue Bonds (GO Zone Bonds), reducing Valero’s debt by $2.3 billion since the second half of 2021
MarketTwits
🇺🇸#JBLU #SAVE #mna #авиа #сша Spirit Airlines расторгла соглашение о слиянии с Frontier Airlines. Пойдет на слияние с JetBlue. В результате, в США будет создана пятая по величине авиакомпания
⚡️🇺🇸#LUV #отчетность
Southwest Airlines Q2 22 Earnings:
- Adj EPS: $1.30 (est $1.17)
- Revenue: $6.7B (est $6.66B)
- Adj Oper Income: $1.17B (est $994.9M)
- Ends Expiration Dates On Flight Credits
Southwest Airlines Q2 22 Earnings:
- Adj EPS: $1.30 (est $1.17)
- Revenue: $6.7B (est $6.66B)
- Adj Oper Income: $1.17B (est $994.9M)
- Ends Expiration Dates On Flight Credits
⚡️🇺🇸#PFE #отчетность
Pfizer Q2 22 Earnings:
- Adj EPS: $2.04 (est $1.81)
- Revenue: $27.7B (est $26.31B)
- Raises Year 2022 Financial Guidance For Rev & Adj EPS
- Doesn’t Anticipate Additional Share Repurchases
- Still See FY Rev $98.0B to $102.0B (est $103.44B)
Pfizer Q2 22 Earnings:
- Adj EPS: $2.04 (est $1.81)
- Revenue: $27.7B (est $26.31B)
- Raises Year 2022 Financial Guidance For Rev & Adj EPS
- Doesn’t Anticipate Additional Share Repurchases
- Still See FY Rev $98.0B to $102.0B (est $103.44B)
⚡️🇺🇸#HOG #отчетность
Harley Davidson
Q2 GAAP EPS of $1.46 beats by $0.39.
Revenue of $1.47B (-3.9% Y/Y) beats by $230M
reaffirms its full-year 2022 outlook
Harley Davidson
Q2 GAAP EPS of $1.46 beats by $0.39.
Revenue of $1.47B (-3.9% Y/Y) beats by $230M
reaffirms its full-year 2022 outlook
⚡️🇺🇸#CMCSA #отчетность
ComCast Q2 22 Earnings:
- Adj EPS: $1.01 (est $0.91)
- Revenue: $30.02B (est $29.7B)
ComCast Q2 22 Earnings:
- Adj EPS: $1.01 (est $0.91)
- Revenue: $30.02B (est $29.7B)
⚡️🇺🇸#MO #отчетность
Altria
Q2 Non-GAAP EPS of $1.26 beats by $0.01.
Revenue of $5.37B (-4.1% Y/Y) misses by $50M
reaffirm our guidance to deliver 2022 full-year adjusted diluted EPS in a range of $4.79 to $4.93. This range represents an adjusted diluted EPS growth rate of 4% to 7% from a $4.61 base in 2021.”
Altria
Q2 Non-GAAP EPS of $1.26 beats by $0.01.
Revenue of $5.37B (-4.1% Y/Y) misses by $50M
reaffirm our guidance to deliver 2022 full-year adjusted diluted EPS in a range of $4.79 to $4.93. This range represents an adjusted diluted EPS growth rate of 4% to 7% from a $4.61 base in 2021.”
This media is not supported in your browser
VIEW IN TELEGRAM
⚡️🇺🇸#TLRY #отчетность
Tilray
Q4 GAAP EPS of -$0.90 misses by $0.81.
Revenue of $153.3M (+7.8% Y/Y) beats by $1.77M.
Fourth Quarter International Cannabis Increased 205% from the Prior Year Q4
Tilray
Q4 GAAP EPS of -$0.90 misses by $0.81.
Revenue of $153.3M (+7.8% Y/Y) beats by $1.77M.
Fourth Quarter International Cannabis Increased 205% from the Prior Year Q4